182 related articles for article (PubMed ID: 35661922)
1. H3K27m3 overexpression as a new, BCL2 independent diagnostic tool in follicular and cutaneous follicle center lymphomas.
Brune MM; Vela V; Bratic Hench I; Dertinger S; Borgmann V; Dirnhofer S; Tzankov A
Virchows Arch; 2022 Sep; 481(3):489-497. PubMed ID: 35661922
[TBL] [Abstract][Full Text] [Related]
2. Concomitant 1p36 deletion and TNFRSF14 mutations in primary cutaneous follicle center lymphoma frequently expressing high levels of EZH2 protein.
Gángó A; Bátai B; Varga M; Kapczár D; Papp G; Marschalkó M; Kuroli E; Schneider T; Csomor J; Matolcsy A; Bödör C; Szepesi Á
Virchows Arch; 2018 Oct; 473(4):453-462. PubMed ID: 29858685
[TBL] [Abstract][Full Text] [Related]
3. The molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma.
Barasch NJK; Liu YC; Ho J; Bailey N; Aggarwal N; Cook JR; Swerdlow SH
Hum Pathol; 2020 Dec; 106():93-105. PubMed ID: 33045225
[TBL] [Abstract][Full Text] [Related]
4. EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas.
Ryan RJ; Nitta M; Borger D; Zukerberg LR; Ferry JA; Harris NL; Iafrate AJ; Bernstein BE; Sohani AR; Le LP
PLoS One; 2011; 6(12):e28585. PubMed ID: 22194861
[TBL] [Abstract][Full Text] [Related]
5. Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
Hamamoto Y; Kukita Y; Kitamura M; Kurashige M; Masaie H; Fuji S; Ishikawa J; Honma K; Wakasa T; Hanamoto H; Hirokawa M; Suzuki A; Morii E; Nakatsuka SI
Histopathology; 2021 Oct; 79(4):521-532. PubMed ID: 33829512
[TBL] [Abstract][Full Text] [Related]
6. BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma.
Burkhard R; Bhagat G; Cogliatti SB; Rossi D; Gaidano G; Pasqualucci L; Novak U
Hematol Oncol; 2015 Mar; 33(1):23-30. PubMed ID: 24496723
[TBL] [Abstract][Full Text] [Related]
7. Primary Cutaneous Follicle Center Lymphomas Expressing BCL2 Protein Frequently Harbor BCL2 Gene Break and May Present 1p36 Deletion: A Study of 20 Cases.
Szablewski V; Ingen-Housz-Oro S; Baia M; Delfau-Larue MH; Copie-Bergman C; Ortonne N
Am J Surg Pathol; 2016 Jan; 40(1):127-36. PubMed ID: 26658664
[TBL] [Abstract][Full Text] [Related]
8. Neoplastic cells do not carry bcl2-JH rearrangements detected in a subset of primary cutaneous follicle center B-cell lymphomas.
Vergier B; Belaud-Rotureau MA; Benassy MN; Beylot-Barry M; Dubus P; Delaunay M; Garroste JC; Taine L; Merlio JP
Am J Surg Pathol; 2004 Jun; 28(6):748-55. PubMed ID: 15166666
[TBL] [Abstract][Full Text] [Related]
9. Primary cutaneous vs secondary cutaneous follicular lymphomas: A comparative study focused on BCL2, CD10, and t(14;18) expression.
Servitje O; Climent F; Colomo L; Ruiz N; García-Herrera A; Gallardo F; Mercadal S; Pomares H; Muniesa C; Martin-Callizo C; Marcoval J; Rovira R; Estrach T; Pujol RM
J Cutan Pathol; 2019 Mar; 46(3):182-189. PubMed ID: 30511443
[TBL] [Abstract][Full Text] [Related]
10. Primary cutaneous follicle center lymphoma with extensive plasmacytic differentiation and t(14;18) in both the lymphoid and plasma cell components.
Kelley JT; Brown NA; Hristov AC; Bresler SC
J Cutan Pathol; 2021 Jul; 48(7):969-974. PubMed ID: 33786907
[TBL] [Abstract][Full Text] [Related]
11. Genomic landscape of cutaneous follicular lymphomas reveals 2 subgroups with clinically predictive molecular features.
Zhou XA; Yang J; Ringbloom KG; Martinez-Escala ME; Stevenson KE; Wenzel AT; Fantini D; Martin HK; Moy AP; Morgan EA; Harkins S; Paxton CN; Hong B; Andersen EF; Guitart J; Weinstock DM; Cerroni L; Choi J; Louissaint A
Blood Adv; 2021 Feb; 5(3):649-661. PubMed ID: 33560380
[TBL] [Abstract][Full Text] [Related]
12. The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas.
Adam P; Baumann R; Schmidt J; Bettio S; Weisel K; Bonzheim I; Fend F; Quintanilla-Martínez L
Hum Pathol; 2013 Sep; 44(9):1817-26. PubMed ID: 23642737
[TBL] [Abstract][Full Text] [Related]
13. Novel markers in pediatric-type follicular lymphoma.
Agostinelli C; Akarca AU; Ramsay A; Rizvi H; Rodriguez-Justo M; Pomplun S; Proctor I; Sabattini E; Linch D; Daw S; Pittaluga S; Pileri SA; Jaffe ES; Quintanilla-Martinez L; Marafioti T
Virchows Arch; 2019 Dec; 475(6):771-779. PubMed ID: 31686194
[TBL] [Abstract][Full Text] [Related]
14. CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas.
Dogan A; Bagdi E; Munson P; Isaacson PG
Am J Surg Pathol; 2000 Jun; 24(6):846-52. PubMed ID: 10843287
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic clues of BCL2-negative, faint, or controversial follicular lymphomas: a study of 103 cases.
Maeshima AM; Taniguchi H; Furukawa H; Hattori D; Sasaki H; Makita S; Iwaki N; Fukuhara S; Munakata W; Izutsu K
Hum Pathol; 2023 May; 135():84-92. PubMed ID: 36702355
[TBL] [Abstract][Full Text] [Related]
16. EZH2 mutations in follicular lymphoma from different ethnic groups and associated gene expression alterations.
Guo S; Chan JK; Iqbal J; McKeithan T; Fu K; Meng B; Pan Y; Cheuk W; Luo D; Wang R; Zhang W; Greiner TC; Chan WC
Clin Cancer Res; 2014 Jun; 20(12):3078-86. PubMed ID: 24634383
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous b-cell lymphomas of follicular and marginal zone types: use of Bcl-6, CD10, Bcl-2, and CD21 in differential diagnosis and classification.
de Leval L; Harris NL; Longtine J; Ferry JA; Duncan LM
Am J Surg Pathol; 2001 Jun; 25(6):732-41. PubMed ID: 11395550
[TBL] [Abstract][Full Text] [Related]
18. Mutations in linker histone genes HIST1H1 B, C, D, and E; OCT2 (POU2F2); IRF8; and ARID1A underlying the pathogenesis of follicular lymphoma.
Li H; Kaminski MS; Li Y; Yildiz M; Ouillette P; Jones S; Fox H; Jacobi K; Saiya-Cork K; Bixby D; Lebovic D; Roulston D; Shedden K; Sabel M; Marentette L; Cimmino V; Chang AE; Malek SN
Blood; 2014 Mar; 123(10):1487-98. PubMed ID: 24435047
[TBL] [Abstract][Full Text] [Related]
19. Similarities of prosurvival signals in Bcl-2-positive and Bcl-2-negative follicular lymphomas identified by reverse phase protein microarray.
Zha H; Raffeld M; Charboneau L; Pittaluga S; Kwak LW; Petricoin E; Liotta LA; Jaffe ES
Lab Invest; 2004 Feb; 84(2):235-44. PubMed ID: 14767488
[TBL] [Abstract][Full Text] [Related]
20. Bcl2-negative follicular lymphomas frequently have Bcl6 translocation and/or Bcl6 or p53 expression.
Guo Y; Karube K; Kawano R; Suzumiya J; Takeshita M; Kikuchi M; Huang GS; Li Q; Ohshima K
Pathol Int; 2007 Mar; 57(3):148-52. PubMed ID: 17295647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]